Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer

No Thumbnail Available
File version
Author(s)
Jaiswal, A
Murakami, K
Elia, A
Shibahara, Y
Done, SJ
Wood, SA
Donato, NJ
Ohashi, PS
Reedijk, M
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
Abstract

Triple-negative breast cancer (TNBC) is a breast cancer subtype that lacks targeted treatment options. The activation of the Notch developmental signaling pathway, which is a feature of TNBC, results in the secretion of proinflammatory cytokines and the recruitment of protumoral macrophages to the tumor microenvironment. While the Notch pathway is an obvious therapeutic target, its activity is ubiquitous, and predictably, anti-Notch therapies are burdened with significant on-target side effects. Previously, we discovered that, under conditions of cellular stress commonly found in the tumor microenvironment, the deubiquitinase USP9x forms a multiprotein complex with the pseudokinase tribbles homolog 3 (TRB3) that together activate the Notch pathway. Herein, we provide preclinical studies that support the potential of therapeutic USP9x inhibition to deactivate Notch. Using a murine TNBC model, we show that USP9x knockdown abrogates Notch activation, reducing the production of the proinflammatory cytokines, C-C motif chemokine ligand 2 (CCL2) and interleukin-1 beta (IL-1β). Concomitant with these molecular changes, a reduction in tumor inflammation, the augmentation of antitumor immune response, and the suppression of tumor growth were observed. The pharmacological inhibition of USP9x using G9, a partially selective, small-molecule USP9x inhibitor, reduced Notch activity, remodeled the tumor immune landscape, and reduced tumor growth without associated toxicity. Proving the role of Notch, the ectopic expression of the activated Notch1 intracellular domain rescued G9-induced effects. This work supports the potential of USP9x inhibition to target Notch in metabolically vulnerable tissues like TNBC, while sparing normal Notch-dependent tissues.

Journal Title

Proceedings of the National Academy of Sciences of the United States of America

Conference Title
Book Title
Edition
Volume

118

Issue

38

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Oncology and carcinogenesis

Pharmacogenomics

Clinical pharmacology and therapeutics

Persistent link to this record
Citation

Jaiswal, A; Murakami, K; Elia, A; Shibahara, Y; Done, SJ; Wood, SA; Donato, NJ; Ohashi, PS; Reedijk, M, Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer, Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (38), pp. e2101592118

Collections